Max Competitors
| MAXHEALTH | 985.75 14.00 1.44% |
Max |
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Max Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Max Healthcare Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Max Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Max and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Max Healthcare Institute does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Max Stock performing well and Max Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Max Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| INDIAGLYCO | 2.29 | (0.06) | 0.00 | (0.14) | 0.00 | 5.48 | 23.17 | |||
| INDOBORAX | 2.70 | 0.01 | (0.02) | 0.14 | 2.86 | 6.42 | 19.96 | |||
| KINGFA | 1.65 | (0.25) | 0.00 | (0.79) | 0.00 | 3.60 | 9.31 | |||
| ALKALI | 1.95 | (0.05) | (0.03) | 0.05 | 2.41 | 3.85 | 26.39 | |||
| MAHLOG | 1.37 | (0.39) | 0.00 | 4.53 | 0.00 | 2.45 | 9.42 | |||
| KREBSBIO | 2.53 | 0.39 | 0.23 | 0.42 | 1.58 | 5.00 | 9.84 | |||
| KNRCON | 1.98 | (0.08) | 0.00 | (1.75) | 0.00 | 3.86 | 10.31 | |||
| MANGCHEFER | 1.66 | 0.14 | 0.04 | 0.39 | 1.75 | 3.60 | 9.87 | |||
| BFINVEST | 2.04 | 0.31 | 0.09 | 1.32 | 2.16 | 5.74 | 17.29 | |||
| FINOPB | 2.28 | (0.24) | 0.00 | (0.45) | 0.00 | 4.29 | 17.99 |
Cross Equities Net Income Analysis
Compare Max Healthcare Institute and related stocks such as India Glycols Limited, Indo Borax Chemicals, and Kingfa Science Technology Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INDIAGLYCO | 585.8 M | 674.1 M | 955.3 M | (1.6 B) | (886.4 M) | (491.2 M) | 350.4 M | 965.3 M | 1.3 B | 1.1 B | 1.3 B | 3.4 B | 1.3 B | 1.7 B | 1.8 B |
| INDOBORAX | 79.2 M | 72.5 M | 114.2 M | 101.2 M | 131 M | 92.3 M | 79.6 M | 134 M | 175.4 M | 169.5 M | 342.6 M | 363.7 M | 506.9 M | 389.8 M | 197.9 M |
| KINGFA | 53.6 M | 249 K | (50.5 M) | (84.8 M) | (30.4 M) | 108 M | 118.3 M | 246.4 M | 190.6 M | 246.2 M | 53.2 M | 306.3 M | 814.1 M | 1.2 B | 1.3 B |
| ALKALI | 79.3 M | (163.5 M) | 47.6 M | (19.6 M) | 2.8 M | 22.6 M | 3.5 M | 13.1 M | 16.9 M | 12.5 M | (12.1 M) | 34.8 M | 29.1 M | 11.3 M | 12.4 M |
| MAHLOG | 244.2 M | 244.2 M | 244.2 M | 366.2 M | 392.6 M | 365.4 M | 455.9 M | 640.1 M | 856.4 M | 551.2 M | 300 M | 370.7 M | 262.8 M | (547.4 M) | (520 M) |
| KREBSBIO | (101.9 M) | (174.4 M) | (104.6 M) | (24.4 M) | (60 M) | (163.2 M) | (160.5 M) | (178.2 M) | (200.1 M) | (288.7 M) | (283.6 M) | (445.3 M) | (246.9 M) | (197.3 M) | (207.1 M) |
| KNRCON | 308.7 M | 468.1 M | 490.7 M | 604.6 M | 697.6 M | 1.3 B | 1.1 B | 2.4 B | 2.7 B | 2.7 B | 4.1 B | 3.8 B | 4.6 B | 7.8 B | 8.2 B |
| MANGCHEFER | 274.4 M | 691 M | 665.7 M | 709.3 M | 375.4 M | (2.4 B) | 194.1 M | 605.8 M | 328.8 M | 645.5 M | 671 M | 878.6 M | 1.3 B | 1.5 B | 1.6 B |
| BFINVEST | 498.7 M | 435 M | 263.7 M | 199.5 M | 187.5 M | 1.3 B | 1.4 B | 1.1 B | 1.3 B | 1.4 B | 2.7 B | 2 B | 2.6 B | 4.3 B | 4.6 B |
| FINOPB | (673.4 M) | (673.4 M) | (673.4 M) | (673.4 M) | (673.4 M) | (673.4 M) | (673.4 M) | (673.4 M) | (623.8 M) | (320.4 M) | 204.7 M | 427.4 M | 650.8 M | 862.2 M | 905.4 M |
Max Healthcare Institute and related stocks such as India Glycols Limited, Indo Borax Chemicals, and Kingfa Science Technology Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Max Healthcare Institute financial statement analysis. It represents the amount of money remaining after all of Max Healthcare Institute operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Max Healthcare Competitive Analysis
The better you understand Max Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Max Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Max Healthcare's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Max Healthcare Competition Performance Charts
Five steps to successful analysis of Max Healthcare Competition
Max Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Max Healthcare Institute in relation to its competition. Max Healthcare's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Max Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Max Healthcare's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Max Healthcare Institute, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Max Healthcare position
In addition to having Max Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Music and Video Thematic Idea Now
Music and Video
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Max Stock
Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.